CNSP
Cns Pharmaceuticals Inc

7,824
Mkt Cap
$1.85M
Volume
5,387.00
52W High
$55.20
52W Low
$2.95
PE Ratio
-0.05
CNSP Fundamentals
Price
$3.07
Prev Close
$2.99
Open
$2.94
50D MA
$5.43
Beta
1.02
Avg. Volume
72,923.95
EPS (Annual)
-$466.44
P/B
0.17
Rev/Employee
$0.00
$3.83
Loading...
Loading...
News
all
press releases
News Placeholder
CNS Pharmaceuticals Stock Declines On Wider Q1 Loss: But Retail Stays Unmoved
The company intends to commence the phase 2 study of its lead program, TPI 287, to treat Glioblastoma Multiforme (GBM) by year-end.
Stocktwits·10mo ago
<
...
1
>

Latest CNSP News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.